Indeed, increases in specifically oleic acid–containing (18:1) DAGs have been shown to drive protein kinase Cε–mediated hepatic insulin resistance in NAFLD (41–43) and also stimulate the androgen receptor to drive obesity and NAFLD-associated hepatocellular cancer (44). The gene discussed is AR; the disease is metabolic dysfunction-associated steatotic liver disease.